Artificial intelligence is outpacing doctors when it comes to detecting a common cancer in men.
A new study from UCLA found that an AI tool identified prostate cancer with 84% accuracy — compared to 67% accuracy for cases detected by physicians, according to a press release from the university.
Unfold AI, made by Avenda Health in California — a software recently cleared by the U.S. Food and Drug Administration — uses an AI algorithm to visualize the likelihood of cancer based on various types of clinical data.
In the study, a team of seven urologists and three radiologists analyzed 50 cases where tumors had been removed, looking for signs of residual cancer.
A few months later, the AI software performed the same analysis.
The “negative margin rate” — a medical term that describes the absence of cancer cells surrounding the removed tissue — was 45 times greater in AI-detected cases, so the chances of cancer being left behind was far less.
